Investors may be asking whether Moderna's current share price reflects its underlying worth, or if the market is mispricing ...

In the latest trading session, Moderna (MRNA) closed at $49.20, marking a -1.66% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.11%. On the other hand, ...

Broader biotech positioning aligns with movements tracked across the nasdaq ecosystem.

They aren't just "pandemic stocks." ...

Moderna's full pipeline may fuel long-term growth.

Piper Sandler expects Moderna to generate $2.07 billion in product sales in 2026, driven largely by its next‑generation COVID vaccine, mNEXSPIKE, according to Investing.com. The FDA is set to review ...